Literature DB >> 19652931

[First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in baden-württemberg: part 1].

Hans Hawighorst1, Gerd Becker, Norbert Hodapp, Frederik Wenz.   

Abstract

PURPOSE: To evaluate the structure quality (medical staff, linear accelerators, and patients) of radiotherapy units based on the clinical audits by the "Arztliche Stelle" (this institution is based on federal German law) in Baden-Württemberg.
MATERIAL AND METHODS: External audits (performed by at least two radiation oncologists, one radiation physicist, and a member of the administration) of recently completed charts by designated reviewers using appropriate checklists developed by the federal task group ("Arztliche Stelle") were used.
RESULTS: In the interval from 2005 to 2007, 60 linear accelerators in 24 radiotherapy units served a population of approximately 10.7 million inhabitants (178,000 inhabitants/linear accelerator). 28,210 people with malignant tumors were treated in these units in 2007. These patients were served by 127 radiation oncologists, 83 radiation physicists, and 235 technologists. The ratio of patients irradiated annually to staff would become 222 (range 85-400) for a radiation oncologist, 339 for a radiation physicist (range 170-538), and 120 for a technologist (range 48-189). In five of seven departments (71%), new staff was employed following the recommendations of the auditors.
CONCLUSION: Clinical audits by the "Arztliche Stelle" are highly effective to evaluate the structure quality of radiotherapy units. Based on these audits realistic data for staff requirements were gained. Making use of these data, guidelines for average minimum personnel necessary for good patient care were calculated. Personnel requirements may vary related to specific needs (teaching, research) of the treatment program and should be accounted for when discussing with the administration. The recommendations of the auditors of the "Arztliche Stelle" resulted in the new employment of additional staff.

Entities:  

Mesh:

Year:  2009        PMID: 19652931     DOI: 10.1007/s00066-009-1972-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.

Authors:  Tilo Wiezorek; Nico Banz; Michael Schwedas; Marcel Scheithauer; Henning Salz; Dietmar Georg; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2005-07       Impact factor: 3.621

Review 2.  Intensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs: issues and how to detect them.

Authors:  Barbara Dobler; Friedlieb Lorenz; Hansjörg Wertz; Martin Polednik; Dirk Wolff; Volker Steil; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

3.  Quality of training in radiation oncology in Germany. Results of a 2006 survey.

Authors:  Robert Semrau; Katja Hansemann; Markus Adam; Nicolaus Andratschke; Thomas Brunner; Frank Heinzelmann; Guido Hildebrandt; Dirk Vordermark; Daniel Zips
Journal:  Strahlenther Onkol       Date:  2008-05       Impact factor: 3.621

4.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

5.  Locoregional failure analysis in head-and-neck cancer patients treated with IMRT.

Authors:  Gabriela Studer; Urs M Luetolf; Christoph Glanzmann
Journal:  Strahlenther Onkol       Date:  2007-08       Impact factor: 3.621

6.  Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.

Authors:  Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jörn Kalz; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

7.  Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives.

Authors:  M Heinrich Seegenschmiedt; Oliver Micke; Norman Willich
Journal:  Strahlenther Onkol       Date:  2004-11       Impact factor: 3.621

  7 in total
  4 in total

1.  Pretreatment verification of dose calculation and delivery by means of measurements with PLEXITOM™ phantom.

Authors:  Paweł Wołowiec; Paweł Kukołowicz; Krzysztof Lis
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-04

2.  A new modification of combining vacuum therapy and brachytherapy in large subfascial soft -tissue sarcomas of the extremities.

Authors:  Maximilian Rudert; Cornelia Winkler; Boris Michael Holzapfel; Hans Rechl; Peter Kneschaurek; Reiner Gradinger; Michael Molls; Barbara Röper
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

3.  [Survey of potential improvements during the course of the radiotherapy treatment--a patient questionnaire].

Authors:  Felix Momm; David Jooss; Carola J Xander; Sonja Adebahr; Viola Duncker-Rohr; Felix Heinemann; Simon Kirste; Marc-Benjamin Messmer; Anca-Ligia Grosu; Gerhild Becker
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

4.  First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in Baden-Württemberg: part 2.

Authors:  Hans Hawighorst; Frederik Wenz; Norbert Hodapp; Gerd Becker
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.